We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$45.5B
AUM Growth
+$5.56B
Cap. Flow
+$2.53B
Cap. Flow %
5.56%
Top 10 Hldgs %
9.95%
Holding
3,224
New
651
Increased
711
Reduced
732
Closed
1,011

Sector Composition

Rank Sector Weight
1 Industrials 12.8%
2 Technology 12.79%
3 Consumer Discretionary 10.45%
4 Financials 8.11%
5 Healthcare 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WINA icon
1701
Winmark
WINA
$1.32B
$775K ﹤0.01%
+2,330
New +$789K
FRHC icon
1702
Freedom Holding
FRHC
$9.79B
$774K ﹤0.01%
9,583
-2,741
-22% -$215K
EL icon
1703
Estee Lauder
EL
$31.8B
$774K ﹤0.01%
3,942
-106,116
-96% -$22.5M
FBNC icon
1704
First Bancorp
FBNC
$2.71B
$771K ﹤0.01%
+25,919
New +$820K
LOB icon
1705
Live Oak Bancshares
LOB
$1.97B
$769K ﹤0.01%
29,225
-15,529
-35% -$366K
SNCY
1706
DELISTED
Sun Country Airlines
SNCY
$766K ﹤0.01%
+34,075
New +$651K
F icon
1707
CALL
Ford
F
$55.4B
$764K ﹤0.01%
50,500
DCGO icon
1708
DocGo
DCGO
$59M
$759K ﹤0.01%
+81,015
New +$711K
DAVA icon
1709
Endava
DAVA
$155M
$758K ﹤0.01%
+14,631
New +$786K
TGI
1710
DELISTED
Triumph Group
TGI
$758K ﹤0.01%
61,256
+2,795
+5% +$31.9K
DOCU
1711
DocuSign
DOCU
$11.1B
$753K ﹤0.01%
14,746
-329,024
-96% -$17.4M
FLNA
1712
Filana Therapeutics
FLNA
$45.7M
$753K ﹤0.01%
30,719
+21,326
+227% +$514K
MLAB icon
1713
Mesa Laboratories
MLAB
$622M
$752K ﹤0.01%
5,850
+3,264
+126% +$497K
LZB icon
1714
La-Z-Boy
LZB
$1.65B
$748K ﹤0.01%
26,124
-365,675
-93% -$10.2M
INFN
1715
DELISTED
Infinera Corporation Common Stock
INFN
$748K ﹤0.01%
154,849
+65,443
+73% +$360K
MEI icon
1716
Methode Electronics
MEI
$600M
$747K ﹤0.01%
22,296
+17,560
+371% +$716K
NBIS
1717
Nebius Group N.V.
NBIS
$58B
$746K ﹤0.01%
39,369
LRN icon
1718
Stride
LRN
$3.23B
$744K ﹤0.01%
+19,978
New +$799K
TTEC icon
1719
TTEC Holdings
TTEC
$83.8M
$742K ﹤0.01%
+21,930
New +$752K
SFNC icon
1720
Simmons First National
SFNC
$3.43B
$742K ﹤0.01%
42,988
+26,907
+167% +$453K
FLL icon
1721
Full House Resorts
FLL
$86.1M
$736K ﹤0.01%
109,857
-17,358
-14% -$119K
CBU icon
1722
Community Bank
CBU
$3.42B
$735K ﹤0.01%
15,669
-12,083
-44% -$592K
HAL icon
1723
Halliburton
HAL
$27.9B
$733K ﹤0.01%
22,219
-11,309
-34% -$357K
SKIN icon
1724
CALL
SkinHealth Systems
SKIN
$89.8M
$730K ﹤0.01%
87,200
-153,900
-64% -$1.6M
INVX
1725
Innovex International
INVX
$2.09B
$726K ﹤0.01%
31,183
-19,873
-39% -$506K

Similar funds

Balyasny Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Balyasny Asset Management held 3,224 positions worth $45.5B, up 14% from $39.9B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Balyasny Asset Management deployed $2.53B of net new capital in Q2 2023, opening 651 new positions and adding to 711 existing holdings. Its largest new stake was Waste Connections: 1,195,081 shares worth $171M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $202M trimmed.

  • Balyasny Asset Management's largest Q2 2023 buy was Waste Connections: 1,195,081 shares worth $171M.
  • Balyasny Asset Management added most to iShares Russell 2000 ETF in Q2 2023, an estimated $427M increase.
  • Balyasny Asset Management's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $202M.
  • Balyasny Asset Management fully exited Carrier Global in Q2 2023, selling an estimated $305M.
  • Balyasny Asset Management's ten largest holdings make up 9.9% of its $45.5B portfolio in Q2 2023.
  • Balyasny Asset Management opened 651 new positions and closed 1,011 in Q2 2023.
  • Balyasny Asset Management's portfolio value rose 14% quarter-over-quarter to $45.5B.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.